sing virtual reality to reduce cognitive biases in psychosis

Phase 2

Recruiting

• Conditions: Psychosis; F20; Schizophrenia

• Registration Number: DRKS00013947
• Lead Sponsor: Asklepios Klinik Nord - Wandsbek

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-06-25
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

current or past psychotic episode (verified via the MINI)
- informed consent

Exclusion Criteria

- history of seizures or epilepsy
- other neurologic disorders

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction of psychotic symptoms, measured with:<br><br>Four weeks after baseline:<br>Positive and Negative Syndrome Scale (PANSS),<br>Psychotic Symptom Rating Scales (PSYRATS)<br><br>Immediatly after the VR (virtual reality) Intervention:<br>Paranoia Checklist,<br>Community Assessment of Psychic Experiences<br>

Secondary Outcome Measures

Name	Time	Method
Feasibility and accaptence of the virtual reality and head-mounted display, measured immediatly after the VR intervention:<br>Simulation Sickness Questionnaire